# Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder

> **NCT01003405** · PHASE3 · WITHDRAWN · sponsor: **Kissei Pharmaceutical Co., Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** KUC-7483

## Key facts

- **NCT ID:** NCT01003405
- **Lead sponsor:** Kissei Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2010-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01003405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01003405, "Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01003405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*